|
|
Article: Study Shows New Product From Novogen Produces Increase in `Protective' Cholesterol Levels.
- Article from:
- Business Wire
- Article date:
- June 1, 1999
CopyrightCOPYRIGHT 1999 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
STAMFORD, Conn.--(BUSINESS WIRE)--June 1, 1999--
A new product under development has been found to stimulate the production of "protective" cholesterol in post-menopausal women, according to a new study sponsored by pharmaceutical company Novogen Limited (Nasdaq: NVGN, ASX: NRT).
The product, known as P-081, is derived from an extract of red clover and contains plant estrogens known as isoflavones. The concept of P-081 comes from current knowledge that a number of different isoflavones have a beneficial effect on the body's production of cholesterol, although the effect is generally modest. The breakthrough with P-081 is the finding that a particular ...